Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 20:13:981.
doi: 10.1186/1471-2458-13-981.

Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting

Affiliations

Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting

Micaela Brandolini et al. BMC Public Health. .

Abstract

Background: The aim of the present study is to test in the feasibility of a screening programme for HCV infection in an Italian prison and to evaluate the treatment outcomes.

Method: Single-centre cross-sectional study carried out in Milan-Opera. The HCV infection prevalence was calculated on the imprisoned population on the January 31 2006, the data on treatment over the following 2 years. Treatment option offered to HCV chronically infected patients was then analysed, reasons for not being treated was evaluated.

Results: Of the 965 inmates, 695 were enrolled in the study, 682 (98%) were males, the median age was 43 years. There were 131 (18.8%) foreigners and 564 (81.2%) Italians. HCV seroprevalence was 22.4%(95% CI:19.4%-25.7%), 60 subjects (38.4%) being HIV co-infected too. Prevalence of HCV infection was significantly higher in HIVAb positive (89.6%; 95% CI:79.7%-95.7%) than in HIVAb negative (15.15%; 95% CI 12.6%-18.3%) (p<0.001). Among Italian inmates HCVAb positivity was significantly higher than among foreigners (p=0.0154). Among HCVAb positive patients, 135 subjects were HCV-RNA positive. Forty-seven (36%) had major clinical contraindication to treatment, 18 (13%) refused the treatment, 7 (5%) moved to other Institute and 27 (20%) were not evaluated by infectious disease specialists. Fifteen patients (43%) who received treatment were considered responders, 9 (26%) were non responders/relapsers, 6 (17%) interrupted treatment due to side effects and 5 (14%) were released during treatment and lost in follow-up.

Conclusions: This study indicates that the proportion of patients in a prison setting receiving diagnosis and treatment for HCV infection remained low.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram that summarizes the data on diagnosis and treatment of patients with HCV infection.

References

    1. Spaulding AC, Weinbaum CM, Lau DT, Sterling R, Seeff LB, Margolis HS, Hoofnagle JH. A framework for management of hepatitis C in prisons. Ann Intern Med. 2006;144(10):762–769. doi: 10.7326/0003-4819-144-10-200605160-00010. - DOI - PubMed
    1. Saiz De La Hoya P, Marco A, García-Guerrero J, Rivera A. Hepatitis C and B prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011;30(7):857–862. doi: 10.1007/s10096-011-1166-5. - DOI - PubMed
    1. Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005;76(3):311–317. doi: 10.1002/jmv.20375. - DOI - PubMed
    1. Sabbatani S, Giuliani R, Fulgaro C, Paolillo P, Baldi E, Chiodo F. HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effetct of counselling on the compliance of proposed tests. Epidemiol Prev. 2004;28(3):163–168. - PubMed
    1. Decreto Ministero della Sanità. Approvazione del progetto obiettivo per la tutela della salute in ambito penitenziario. 2000. http://www.medicoeleggi.com/argomenti00/italia1/12447.htm.

Publication types